Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Taranger

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Clinical and Diagnostic Laboratory Immunology|August 31, 2001
Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussisB Trollfors, T Lagergård, J Taranger, et al.
Marseille Medical|January 1, 1970
[Rifampicin and hepatic puncture biopsy]H Bonneau, J P Girbal, R Alibert, et al.
Developments in Biological Standardization|January 1, 1991
Immunologic evaluation of a pertussis toxoid vaccineJ B Robbins, B Trollfors, J Taranger, et al.
Journal of Clinical Microbiology|March 21, 1998
Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infectionsL Lind-Brandberg, C Welinder-Olsson, T Lagergård, et al.
The Pediatric Infectious Disease Journal|October 1, 1993
Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccineJ B Robbins, M Pittman, B Trollfors, et al.
Advances in Experimental Medicine and Biology|January 16, 1999
Immunity to pertussis. Not all virulence factors are protective antigensJ B Robbins, R Schneerson, D A Bryla, et al.
The Journal of Pediatrics|June 1, 1990
Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old childrenB A Claesson, R Schneerson, B Trollfors, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assayG Zackrisson, F Arminjon, I Krantz, et al.
The Pediatric Infectious Disease Journal|January 1, 1994
Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infantsJ Isacson, B Trollfors, J Taranger, et al.
Pediatrics|December 4, 2001
Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccineJ Taranger, B Trollfors, E Bergfors, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Clinical and Diagnostic Laboratory Immunology|August 31, 2001
Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussisB Trollfors, T Lagergård, J Taranger, et al.
Marseille Medical|January 1, 1970
[Rifampicin and hepatic puncture biopsy]H Bonneau, J P Girbal, R Alibert, et al.
Developments in Biological Standardization|January 1, 1991
Immunologic evaluation of a pertussis toxoid vaccineJ B Robbins, B Trollfors, J Taranger, et al.
Journal of Clinical Microbiology|March 21, 1998
Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infectionsL Lind-Brandberg, C Welinder-Olsson, T Lagergård, et al.
The Pediatric Infectious Disease Journal|October 1, 1993
Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccineJ B Robbins, M Pittman, B Trollfors, et al.
Advances in Experimental Medicine and Biology|January 16, 1999
Immunity to pertussis. Not all virulence factors are protective antigensJ B Robbins, R Schneerson, D A Bryla, et al.
The Journal of Pediatrics|June 1, 1990
Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old childrenB A Claesson, R Schneerson, B Trollfors, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assayG Zackrisson, F Arminjon, I Krantz, et al.
The Pediatric Infectious Disease Journal|January 1, 1994
Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infantsJ Isacson, B Trollfors, J Taranger, et al.
Pediatrics|December 4, 2001
Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccineJ Taranger, B Trollfors, E Bergfors, et al.
Pageof 12